HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene

Gene Therapy

Volumn 3, Issue 11, 1996, Pages 1002-1009

  Sandig, V ^a   Loser P ^a   Lieber, A ^b   Kay, M A ^b   Strauss, M ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NONE   (Germany)

Author keywords

Adenovirus; HBV promoters; LDL receptor; Liver; Liver specific gene expression

Indexed keywords

IMMEDIATE EARLY PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; EXPRESSION VECTOR; GENE THERAPY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; LIVER; MICE; PROMOTER REGIONS (GENETICS); RECEPTORS, LDL; RECOMBINATION, GENETIC; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; HEPATITIS B VIRUS;

EID: 0029961248     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812-2816.
2. Ishibashi S et al. Hypercholesterolemia in low density hpoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92: 883-893.
3. Kozarsky KF et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994; 269: 13695-13701.
4. Li J et al. In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J Clin Invest 1995; 95: 768-773.
5. Connelly S et al. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum Gene Ther 1995; 6: 185-193.
6. Connelly S et al. High-level tissue-specific expression of functional human factor VIII in mice. Hum Gene Ther 1996; 7: 183-195.
7. Smith TAG et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993; 5: 397-402.
8. Kay MA et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 1994; 91: 2353-2357.
9. Jaffe HA et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992; 1: 372-378.
10. Mittal SK et al Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res 1993; 28: 67-90.
11. Kass-Eisler A et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1994; 1: 395-402.
12. Huard J et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 1995; 2: 107-115.
13. Vrancken-Peeters M-JTFD, Lieber A, Perkins J, Kay MA. Method for multiple portal vein infusions in mice: quantification of adenovirus-mediated hepatic gene transfer. Biotechniques 1996; 20: 278-285.
14. Torres JM et al. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J Virol 1996; 70: 3770-3780.
15. Hatzoglou M et al. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol Chem 1990; 265: 17285-17293.
16. Kay MA et al. Hepatic gene therapy: persistent expression of human α1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther 1992; 3: 641-647.
17. Wilson JM et al. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J Biol Chem 1992; 267: 963-967.
18. Ferkol T et al. Regulation of the phosphoenolpyruvate carboxykinase/human factor IX gene introduced into the livers of adult rats by receptor-mediated gene transfer. FASEB J 1993; 7: 1081-1091.
19. Hafenrichter DG et al. Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res 1994; 56: 510-517.
20. Hafenrichter DG et al. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 1994; 10: 3394-3404.
21. Rettinger SD et al. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci USA 1994; 91: 1460-1464.
22. Friedman JM, Babiss LE, Clayton DF, Darnell JE. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol Cell Biol 1986; 6: 3791-3797.
23. Hayashi Y, DePaoli AM, Burant CF, Refetoff S. Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J Biol Chem 1994; 269: 23872-23875.
24. Kaneko S et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995; 55: 5283-5287.
25. Imler JL et al. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. Gene Ther 1996; 3: 49-58.
26. Loser P, Sandig V, Kirillova I, Strauss M. Evaluation of HBV promoters for use in hepatic gene therapy. Biol Chem Hoppe-Seyler 1996; 377: 187-193.
27. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802-8806.
28. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 1979; 17: 683-689.
29. Babiss LE, Friedman JM, Darnell JE. Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters. Mol Cell Biol 1986; 6: 3798-3806.
30. Huber BE, Cynthia AR, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepaiocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991; 88: 8039-8043.
31. Parker Ponder KP et al. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum Gene Ther 1991; 2: 41-52.
32. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
33. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988; 163: 614-617.
34. Lieber A, Sandig V, Strauss M. A mutant T7 phage promoter is specifically transcribed by T7-RNA polymerase in mammalian cells. Eur J Biochem 1993; 217: 387-394.
35. Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994; 47: 157-166.